Neurokinin B TFA

Neurokinin B TFA is a synthetic peptide corresponding to the endogenous neuropeptide Neurokinin B, presented as its trifluoroacetate salt. As a member of the tachykinin peptide family, Neurokinin B plays a pivotal role in neurotransmission and neuroendocrine regulation, acting primarily through the neurokinin-3 (NK3) receptor. Its well-characterized sequence and receptor specificity have made it an essential tool in neurobiology, endocrinology, and peptide signaling research. The availability of the TFA salt form ensures compatibility with a wide range of experimental protocols, facilitating its integration into both in vitro and in vivo studies focused on understanding peptide-mediated signaling pathways.

Receptor pharmacology: Neurokinin B analogs are widely employed in receptor binding and activation assays to elucidate the pharmacological properties of the NK3 receptor. By serving as a selective agonist, the peptide enables researchers to probe receptor-ligand interactions, assess downstream signaling cascades, and compare the efficacy of novel NK3-targeted compounds. These studies are foundational for mapping tachykinin receptor distribution and understanding the molecular determinants of receptor specificity.

Neuroendocrine research: The peptide is instrumental in studies investigating the regulation of hormone secretion, particularly within the hypothalamic-pituitary-gonadal (HPG) axis. Neurokinin B is known to modulate the release of gonadotropin-releasing hormone (GnRH), thereby influencing reproductive hormone dynamics. Experimental application of the peptide allows for the controlled study of peptide-driven neuroendocrine feedback mechanisms, contributing to the broader understanding of reproductive physiology and neuropeptide signaling networks.

Neuronal signaling studies: As a well-defined tachykinin, Neurokinin B is utilized to dissect mechanisms of synaptic transmission and neuronal excitability in central and peripheral nervous system models. The peptide's ability to induce depolarization and modulate neurotransmitter release provides a robust platform for exploring neuropeptide-induced changes in neuronal circuitry. Such studies are key for unraveling the physiological roles of tachykinins in neural communication and plasticity.

Peptide structure-activity relationship (SAR) analysis: The synthetic availability and defined sequence of Neurokinin B TFA make it an excellent candidate for SAR studies aimed at optimizing peptide ligands for NK3 and related receptors. By serving as a reference compound, it enables systematic evaluation of amino acid substitutions, backbone modifications, and labeling strategies. These investigations are vital for the rational design of novel peptide analogs with enhanced receptor selectivity, stability, or functional activity.

Analytical standard: The well-characterized nature of this peptide supports its use as a quantitative or qualitative standard in analytical techniques such as HPLC, mass spectrometry, or immunoassays. By providing a reliable reference point, Neurokinin B TFA facilitates the calibration and validation of peptide detection methods, ensuring accuracy and reproducibility in analytical workflows involving tachykinins or related neuropeptides.

1. Implications of ligand-receptor binding kinetics on GLP-1R signalling

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes